Munts A G, van Genderen P J, Dippel D W, van Kooten F, Koudstaal P J
Department of Neurology, University Hospital Rotterdam, The Netherlands.
J Neurol. 1998 Jan;245(1):21-5. doi: 10.1007/s004150050169.
We analysed the results of coagulation studies in an unselected series of young adults with acute cerebral ischaemia. Our aims were (a) to determine the prevalence of coagulation disorders among these patients, (b) to investigate the relation between the presence of coagulation abnormalities and large vessel disease or potential sources of cardiac embolism and (c) to evaluate the occurrence of thrombotic events in patients with or without coagulation disorders. One hundred and twenty consecutively admitted patients (53 men, 67 women, median age 38 years, range 15-45) who presented with acute cerebral infarction (n = 89) or a transient ischaemic attack (n = 31) were evaluated. Diagnostic studies consisted of electrocardiography, echocardiography, duplex scanning, and/or angiography. Coagulation studies included activity tests of protein S, protein C, antithrombin, plasminogen, measurement of immunoglobulin G (IgG) anticardiolipin antibodies (ACLA), and a dilute prothrombin assay. Initially, 30 patients had increased ACLA titres and 28 had an abnormal dilute prothrombin assay, suggesting lupus anticoagulant. Decreased protein S, protein C and antithrombin activity were detected in 20, 3 and 3 patients, respectively, excluding patients in whom the abnormalities could be explained by the use of medication, by pregnancy or puerperium. We detected a decreased activity of plasminogen in 5 patients. The disorders could be confirmed by a second assessment in only 2 patients with a protein S deficiency, in none of the patients with a protein C or antithrombin deficiency and in 1 patient with plasminogen deficiency. However, the abnormalities persisted in 19 of 21 patients with increased anticardiolipin IgG titres and in 9 of 20 patients with lupus anticoagulant. A confirmed coagulation disorder was not associated with stroke type or vascular risk factors, but it was more common among patients with large vessel disease (odds ratio: 3.8, 95% confidence interval (CI): 1.1-12.8). Sixteen patients had a recurrent thromboembolic event, but the risk of recurrence was not increased among patients with a confirmed coagulation disorder. Our results suggest that idiopathic coagulation disorders are found in about a quarter of young stroke patients. They are difficult to predict and probably interact with other risk factors.
我们分析了一系列未经挑选的急性脑缺血青年成人的凝血研究结果。我们的目的是:(a) 确定这些患者中凝血障碍的患病率;(b) 研究凝血异常的存在与大血管疾病或心脏栓塞潜在来源之间的关系;(c) 评估有或无凝血障碍患者血栓形成事件的发生率。对连续收治的120例患者(53例男性,67例女性,中位年龄38岁,范围15 - 45岁)进行了评估,这些患者表现为急性脑梗死(n = 89)或短暂性脑缺血发作(n = 31)。诊断性检查包括心电图、超声心动图、双功扫描和/或血管造影。凝血研究包括蛋白S、蛋白C、抗凝血酶、纤溶酶原的活性检测,免疫球蛋白G(IgG)抗心磷脂抗体(ACLA)的测定,以及稀释凝血酶原试验。最初,30例患者的ACLA滴度升高,28例患者的稀释凝血酶原试验异常,提示存在狼疮抗凝物。分别在20例、3例和3例患者中检测到蛋白S、蛋白C和抗凝血酶活性降低,排除了因用药、妊娠或产褥期导致异常的患者。我们在5例患者中检测到纤溶酶原活性降低。仅在2例蛋白S缺乏的患者中通过第二次评估证实了这些障碍,蛋白C或抗凝血酶缺乏的患者中均未证实,纤溶酶原缺乏的患者中有1例证实。然而,21例ACLA IgG滴度升高的患者中有19例以及20例狼疮抗凝物患者中有9例异常持续存在。确诊的凝血障碍与中风类型或血管危险因素无关,但在大血管疾病患者中更常见(比值比:3.8,95%置信区间(CI):1.1 - 12.8)。16例患者发生了复发性血栓栓塞事件,但确诊凝血障碍的患者复发风险并未增加。我们的结果表明,约四分之一的青年中风患者存在特发性凝血障碍。它们难以预测,可能与其他危险因素相互作用。